Clerio Vision, Inc.:
Novel ophthalmic technology to treat refractive error addressing multi-billion contact lens and corneal vision correction markets. Based on Nobel Prize winning femto-second laser technology developed by Bausch & Lomb and the University of Rochester. Clerio's Omnifocal contact lenses provide superior optics addressing significant unmet needs for presbyopia (FDA submission late 2020). Clerio's non-surgical flapless corneal vision correction solution expected to unlock LASIK market opportunity (safety studies completed, efficacy late 2020). $40M raised to date.
US - Middle Atlantic
Medical Device, Medical Technology
1892 S. Winton Rd.
Rochester, NY 14618